LD Logo.png
Lowey Dannenberg Notifies Venture Global, Inc. (“Venture Global” or the “Company”) (NYSE: VG) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm
28 févr. 2025 10h17 HE | Lowey Dannenberg, P.C.
NEW YORK, Feb. 28, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against...
James (Josh) Wilson Faruqi & Faruqi, LLP
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Venture
26 févr. 2025 10h57 HE | Faruqi & Faruqi LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Venture To Contact Him Directly To Discuss Their Options If...
LD Logo.png
Lowey Dannenberg Notifies Venture Global, Inc. (“Venture Global” or the “Company”) (NYSE: VG) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $50,000 in Losses to Contact the Firm
21 févr. 2025 11h22 HE | Lowey Dannenberg, P.C.
NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, announces the filing of a class action lawsuit against...
Faruqi & Faruqi, James (Josh) Wilson
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Venture
18 févr. 2025 12h44 HE | Faruqi & Faruqi LLP
If you purchased or otherwise acquired stock of Venture pursuant and/or traceable to Venture’s registration statement for the initial public offering held on or about January 24, 2025 and would like...
Flat White@3x (1).png
Brickeye Named to Inaugural “Foresight 50” List Of Canada’s Most Investible Cleantech Ventures
07 nov. 2024 13h01 HE | Brickeye
Brickeye Named to Inaugural “Foresight 50” List of Canada’s Most Investable Cleantech Ventures
Synox Logo.jpg
SynOx Therapeutics Adds New Investor and Capital to Series B Financing, Raising Total to $92 Million, and Doses First Patients in Phase 3 Trial
30 oct. 2024 07h00 HE | SynOx Therapeutics Limited
Gilde Healthcare Leads Series B Extension, Joining Premier Syndicate of Leading Life Science Investors Funding Supports Registrational Phase 3 TANGENT Trial of Emactuzumab, a Best-in-Class CSF-1...
Screenshot 2024-07-31 at 10.24.18 AM.png
Y Innovations Group Expands Ecosystem with Yung Ventures and Y Innovations Studios
31 juil. 2024 13h10 HE | Y Innovations Group
BOSTON, July 31, 2024 (GLOBE NEWSWIRE) -- Y Innovations Group (“YI Group” or “the Group”) is pleased to announce the expansion of the Y Innovations ecosystem through the official launch of the Y...
blog-image
gaiia Raises Series A Led by Inovia Capital to Revolutionize Customer Experience for Internet Service Providers
27 juin 2024 08h00 HE | gaiia
gaiia, the innovative operating system designed specifically for Internet Service Providers (ISPs), has successfully raised US$13.2M in a Series A
Regeneron Ventures Launches with $500 Million Commitment to Fuel Promising Biotechnology Innovation
15 avr. 2024 04h00 HE | Regeneron Ventures
GREENWICH, Conn., April 15, 2024 (GLOBE NEWSWIRE) -- Regeneron Ventures announces its formation as a venture capital fund focused on promising biopharmaceutical, health care and health technology...
SURO CAPITAL_highres CROPPED.jpg
SuRo Capital Corp. Fourth Quarter and Fiscal Year 2023 Preliminary Investment Portfolio Update
16 janv. 2024 16h05 HE | SuRo Capital Corp.
NEW YORK, Jan. 16, 2024 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: SSSS) today provided the following preliminary update on its investment...